New Center for Bionics and Pain Research; CBPR, established in Gothenburg
Integrum AB would like to offer its warmest congratulations to Dr. Max Ortiz Catalán (former Head of R&D at Integrum), Chalmers University of Technology, and Sahlgrenska University Hospital for the establishment of the CBPR Center.
The interdisciplinary research center has been established to promote the further development and clinical implementation of novel technologies to treat sensory and motor impairments, such as amputations or nerve injuries. Thanks to generous donations, the Center for Bionics and Pain Research (CBPR) will help patients regain quality of life through world-leading technologies and treatments, developed by engineering and medical professionals working closely together.
While the establishment has been made possible through collaboration of many parties, Integrum AB is quite pleased to see that its OPRATM Implant System, e- OPRATM Implant System, NeuromotusTM and related technologies, will play an integral role in the future of the CBPR and the further development of ground-breaking amputee care.
For further information, please contact:
Maria Lopez, CEO
Cell. +46 (0) 708-46 10 69
Email: maria.lopez@integrum.se
Certified Adviser:
Erik Penser Bank AB
Tel. +46 (0) 8 463 8000
Email: certifiedadviser@penser.se
Integrum AB is a publicly traded company (INTEG B: Nasdaq First North exchange) based outside of Gothenburg, Sweden with a U.S. subsidiary in San Francisco, CA. Since 1990 the OPRA™ Implant System has been helping individuals with amputations towards an improved quality of life. Thorough surgical experience gained over more than three decades from 500 surgeries in 14 countries has led to the development of Integrum’s system for bone-anchored prosthetics – a beneficial alternative to the traditionally used socket prosthesis. Integrum’s OPRA™ Implant System was approved by the U.S. Food and Drug Administration (FDA) in 2015 for use in the U.S. under a Humanitarian Use Device (HUD) designation which was reviewed through the Humanitarian Device Exemption (HDE) pathway. The OPRA™ Implant System is the only FDA approved medical device for above-knee, bone-anchored prosthetics available in the U.S. More information on the company and its innovative solutions for amputees can be found at www.integrum.se.